• Price

Supplier Type

• Manufacturer
• Trader
• Reagent
• contract manufacturer
• custom synthesis

Supplier Region

• Hyderabad(7)
• Gujarat(15)
• Maharashtra(14)
• Rajasthan(1)
• Karnataka(4)
• New Delhi(2)
• Delhi(3)
• Vadodara(6)
• Haryana(3)
• Mumbai(14)
• Uttar Pradesh(2)
• Tamil Nadu(2)
• Ahmedabad(5)
• Nagpur(2)
• Andhra Pradesh(2)
• Himachal Pradesh(1)
• Pune(1)

Purity

• VETRANAL?, analytical standard, mixture of isomers
• VETRANAL?, analytical standard
• United States Pharmacopeia (USP) Reference Standard
• Type VI, lyophilized powder
• Type IV-S, lyophilized powder, γ-irradiated, BioReagent, suitable for cell culture
• Type IV-S, lyophilized powder, aseptically processed, BioReagent, suitable for cell culture
• Type IV, lyophilized powder
• tested according to Ph. Eur.
• tech. 10.00%
• suspension, 10,000?unit/mL in DPBS, BioReagent, suitable for cell culture
• suitable for plant cell culture, BioReagent
• suitable for plant cell culture
• suitable for microbiology
• suitable for cell culture
• solid
• Sepharose? conjugate, buffered aqueous suspension
• Selectophore?, function tested, ≥98.0% ((Total homologs), HPLC)
• Ready Made Solution, from Streptomyces alboniger, 10?mg/mL in H2O, suitable for cell culture
• Ready Made Solution, 100?mg/mL in ethanol/water, 0.2 μm filtered
• powder, γ-irradiated, BioXtra, suitable for cell culture
• powder, BioReagent, suitable for cell culture, suitable for plant cell culture
• powder, BioReagent, suitable for cell culture
• powder, ≥98% (TLC)
• powder
• phyproof? Reference Substance
• Pharmaceutical Secondary Standard
• peroxidase conjugate, lyophilized powder
• penicillin analog
• NLT 95%
• mixture of Kanamycin A (main component) and Kanamycin B and C
• Min. 99%
• meets USP testing specifications, powder
• lyophilized powder, recombinant, expressed in E. coli
• lyophilized powder, BioReagent, suitable for cell culture
• lincosamide antibiotic
• InSolution, ≥99%
• InSolution, ≥97%, 1 mM solution, protein kinase inhibitor
• InSolution, ≥95%, 25 mM in DMSO
• IgG fraction of antiserum, buffered aqueous solution
• HCl dihydrate 95%
• Greater than 99%
• from Streptomyces parvulus, ≥98% (HPLC)
• from Streptomyces luteosporeus, ≥95% (HPLC)
• from Streptomyces chattanoogensis, ≥95% (HPLC)
• from Sorangium cellulosum, ≥98% (HPLC)
• from Penicillium citrinum, ≥98% (HPLC)
• from Penicillium brefeldianum, Ready Made Solution, 10?mg/mL in DMSO
• from Penicillium brefeldianum, ≥99% (HPLC and TLC)
• for synthesis
• for molecular biology, ≥95% (HPLC)
• FITC conjugate, Type IV, lyophilized powder
• European Pharmacopoeia (EP) Reference Standard
• Endotoxin (BET) 10EU/mg
• Endotoxin (BET) 0.05EU/mg
• Dye content 95?%
• Dye content ≥55?%
• clone 893CT29.1.1, IgG fraction of antiserum, buffered aqueous solution
• certified reference material, pharmaceutical secondary standard
• certified reference material, 100?μg/mL in chloroform, ampule of 1?mL
• Certified Reference Material
• Cefaperazone Sodium)
• British Pharmacopoeia (BP) Reference Standard
• biotin conjugate, Type IV, lyophilized powder
• BioReagent, suitable for fluorescence, ≥98.0% (NT)
• anytical standard
• Antiprotozoal agent and angiogenesis inhibitor.
• antibacterial MurA inhibitor
• Animal Component-free
• anhydrous basis)
• and E (7%) isomers 99% (HPLC)
• analytical standard
• An antifungal antibiotic that inhibits sterol and fatty acid biosynthesis.
• agarose conjugate, Type VI, saline suspension
• A polyene antifungal antibiotic effective against yeast and mycoplasma.
• ≥99% (HPLC)
• ≥99% (HPLC and TLC), BioXtra, for molecular biology
• 99%
• >99%
• 99 %
• 98-102%
• 98.0-102.0% (HPLC)
• >98.0%(T)(qNMR)
• >98.0%(T)(HPLC)
• >98.0%(T)
• >98.0%(N)
• >98.0%(HPLC)(N)
• >98.0%(HPLC)
• ≥98.0% (HPLC)
• 98%min
• ≥98%, synthetic
• ≥98% Z isomer
• 98% Min
• ≥98% (TLC)
• ≥98% (HPLC), solid
• >98% (HPLC), powder
• ≥98% (HPLC), powder
• ≥98% (HPLC), from Cephalosporium caerulens
• ≥98% (HPLC), film
• ≥98% (HPLC)
• >98%
• 98%
• 97-99%
• >97.0%(N)
• >97.0%(HPLC)(N)
• >97.0%(HPLC)
• ≥97% (HPLC)
• >96.0%(GC)
• 96%
• 95-103%
• 95.0-102.0% anhydrous basis
• >95.0%(T)(HPLC)
• >95.0%(HPLC)(qNMR)
• >95.0%(HPLC)
• ≥95% (HPLC), powder
• ≥95% (HPLC)
• ≥95% (HPLC and TLC)
• 95%
• >94.0%(N)
• 920
• >92.0%(HPLC)
• ≥92% (HPLC), powder
• >90.0%(N)
• >90.0%(HPLC)
• ≥90.0% (Cephradine, HPLC)
• ≥90%, powder
• ≥90% (HPLC)
• 90%
• 90 % Above
• 870 - 1015 μg/mg anhydrous basis
• 86-100%
• 860u/mg
• 85011426
• ≥85% (HPLC)
• 800U/mg
• 8?mg/mL in 0.9% NaCl, 0.1 μm filtered, BioReagent, suitable for cell culture
• 795ug/mg
• 750mcg/mg
• ≥75% α-anomer basis, ≥98% (HPLC), powder
• 720 IU/mg
• ≥634ug/mg
• ≥630ug/mg
• >600IU/mg
• 590ug/mg
• 50 - 60?mg/mL in 0.9% NaCl, BioReagent, liquid, 0.1 μm filtered, suitable for cell culture
• ≥4,400?USP units/mg
• 1300u/mg
• 100?μg/mL in acetonitrile, analytical standard
• 100%
• 10?mg/mL in H2O, ≥98% (HPLC), Cell culture tested
• 10?mg/mL in DMSO
• 10?mg/mL in 0.9% NaCl, 0.1 μm filtered, BioReagent, suitable for cell culture
• 10%
• ~50?μg/mL in acetonitrile, analytical standard
• ~2.5% (γ-irradiated Pimaricin), aqueous suspension
• ~100?μg/mL in acetonitrile, analytical standard
• (BET) 0.05EU/mg

Package

• 100μg
• 0.1mg
• 200μg
• 250μg
• 0.5mg
• 500μg
• 1mg
• 2mg
• 5mg
• 10mg
• 15mg
• 20mg
• 25mg
• 40mg
• 50mg
• 60mg
• 70mg
• 75mg
• 80mg
• 100mg
• 110mg
• 120mg
• 125mg
• 150mg
• 160mg
• 170mg
• 180mg
• 200mg
• 250mg
• 260mg
• 300mg
• 350mg
• 700mg
• SAMPLE-K
• 400mg
• 500mg
• 0.5mL
• 1gm
• 1g
• 1mL
• 2g
• 2mL
• 5gm
• 5mL
• 5g
• 10gm
• 10g
• 10x1mL
• 10mL
• 20mL
• 25gm
• 25mL
• 25g
• 50g
• 1vial
• 50mL
• 100mL
• 100g
• 2ea
• 100gm
• 250g
• 500gm
• 500g
• 1kg
• 5kg
• 10kg
• 25kg
• 100kg
• 1 Gms
• 1Gms
• 1MT
• 2Gms
• 5vials
• 5Gms
• 5units
• 10Gms
• 18%
• 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
• 50kg
• 25Gms
• 200μL
• 500000units
• 25000000units
• 85011426-DNA-5UG
• 0.18
• 100 Mg
• 100Gms
• 400μL
• 5000000units